BRAF T1796A transversion mutation in various thyroid neoplasms

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 3, 2004, Pages 1365-1368

  Xing, M ^a   Vasko, V ^d,f   Tallini, G ^c,g   Larin, A ^b   Wu, Gujun ^a   Udelsman, R ^c   Ringel, M D ^d,e,f   Ladenson, P W ^a   Sidransky, D ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Transplantation of Endocrine Organs and Tissues   (Ukraine)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d WASHINGTON HOSPITAL CENTER   (United States)

^e OHIO STATE UNIVERSITY   (United States)

^f THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^g BELLARIA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

B TYPE RAF KINASE; GENOMIC DNA; PROTEIN KINASE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANAPLASTIC CARCINOMA; ARTICLE; CANCER PATIENT; CHERNOBYL ACCIDENT; CHILD; CONTROLLED STUDY; DNA SEQUENCE; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GEOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; NORTH AMERICA; POPULATION RESEARCH; PRIORITY JOURNAL; RADIATION EXPOSURE; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; THYROID ADENOMA; THYROID FOLLICULAR CARCINOMA; THYROID HYPERPLASIA; THYROID MEDULLARY CARCINOMA; THYROID PAPILLARY CARCINOMA; UKRAINE;

ACCIDENTS, RADIATION; ADULT; EXONS; HUMANS; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; POINT MUTATION; PREVALENCE; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS C-RAF; THYROID NEOPLASMS;

EID: 1642323622     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-031488     Document Type: Article

References (29)

1. Hundahl SA, Fleming ID, Fremgen AM, Menck HR 1998 A National Cancer Data Base report on 53,356 cases of thyroid carcinoma treated in the U. S., 1985-1995. Cancer 83:2638-2648
2. Santoro M, Carlomagno F, Hay ID, Herrmann MA, Grieco M, Melillo R, Pierotti MA, Bongarzone I, Della Porta G, Berger N, Peix JL, Paulin C, Fabien N, Vecchio G, Jenkins RB, Fusco A 1992 Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype. J Clin Invest 89:1517-1522
3. Jhiang SM, Caruso DR, Gilmore E, Ishizaka Y, Tahira T, Nagao M, Chiu IM, Mazzaferri EL 1992 Detection of the PTC/retTPC oncogene in human thyroid cancers. Oncogene 7:1331-1337
4. Fugazzola L, Pilotti S, Pinchera A, Vorontsova TV, Mondellini P, Bongarzone I, Greco A, Astakhova L, Butti MG, Demidchik EP 1995 Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident. Cancer Res 55:5617-5620
5. Nikiforov YE, Rowland JM, Bove KE, Monforte-Munoz H, Fagin JA 1997 Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children. Cancer Res 57:1690-1694
6. Bounacer A, Wicker R, Caillou B, Cailleux AF, Sarasin A, Schlumberger M, Suarez HG 1997 High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation. Oncogene 15:1263-1273
7. Lemoine NR, Mayall ES, Wyllie FS, Farr CJ, Hughes D, Padua RA, Thurston V, Williams ED, Wynford-Thomas D 1988 Activated ras oncogenes in human thyroid cancers. Cancer Res 48:4459-4463
8. Pierotti MA, Bongarzone I, Borello MG, Greco A, Pilotti S, Sozzi G 1996 Cytogenetics and molecular genetics of carcinomas arising from thyroid epithelial follicular cells. Genes Chromosomes Cancer 16:1-14
9. Vasko V, Ferrand M, Di Cristofaro J, Carayon P, Henry JF, de Micco C 2003 Specific pattern of RAS oncogene mutations in follicular thyroid tumors. J Clin Endocrinol Metab 88:2745-2752
10. Nikiforova MN, Lynch RA, Biddinger PW, Alexander EK, Dorn 2nd GW, Tallini G, Kroll TG, Nikiforov YE 2003 RAS point mutations and PAX8-PPAR γ rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. J Clin Endocrinol Metab 88:2318-2326
11. Kroll TG, Sarraf P, Pecciarini L, Chen CJ, Mueller E, Spiegelman BM, Fletcher JA 2000 PAX8-PPARγ1 fusion oncogene in human thyroid carcinoma. Science 289:1357-1360
12. Fagin JA, Matsuo K, Karmakar A, Chen DL, Tang SH, Koeffler HP 1993 High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas. J Clin Invest 91:179-184
13. Satta MA, Nanni S, Della Casa S, Pontecorvi A 2000 Molecular biology of thyroid neoplasms. Rays 25:151-161
14. Clayman GL, El-Baradie TS 2003 Medullary thyroid cancer. Otolaryngol Clin North Am 36:91-105
15. Neumann HP, Bausch B, McWhinney SR, Bender BU, Gimm O, Franke G, Schipper J, Klisch J, Altehoefer C, Zerres K, Januszewicz A, Eng C, Smith WM, Munk R, Manz T, Glaesker S, Apel TW, Treier M, Reineke M, Walz MK, Hoang-Vu C, Brauckhoff M, Klein-Franke A, Klose P, Schmidt H, Maier-Woelfle M, Peczkowska M, Szmigielski C, Eng C, Freiburg-Warsaw-Columbus Pheochromocytoma Study Group 2002 Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 346:1459-1466
16. Kimura ET, Nikiforova MN, Zhu Z, Knauf JA, Nikiforov YE, Fagin JA 2003 High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res 63:1454-1457
17. Cohen Y, Xing M, Mambo E, Guo Z, Wu G, Trink B, Beller U, Westra WH, Ladenson PW, Sidransky D 2003 BRAF mutation in papillary thyroid carcinoma. J Natl Cancer Inst 95:625-627
18. Soares P, Trovisco V, Rocha AS, Lima J, Castro P, Preto A, Maximo V, Botelho T, Seruca R, Sobrinho-Simoes M 2003 BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC. Oncogene 22:4578-4580
19. Xu X, Quiros RM, Gattuso P, Ain KB, Prinz RA 2003 High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines. Cancer Res 63:4561-4567
20. Hilger RA, Scheulen ME, Strumberg D 2002 The Ras-Raf-MEK-ERK pathway in the treatment of cancer. Onkologie 25:511-518
21. Mercer KE, Pritchard CA 2003 Raf proteins and cancer: B-Raf is identified as a mutational target. Biochim Biophys Acta 1653:25-40
22. Sithanandam G, Druck T, Cannizzaro LA, Leuzzi G, Huebner K, Rapp UR 1992 B-raf and a B-raf pseudogene are located on 7q in man. Oncogene 7:795-799
23. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JW, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR, Futreal PA 2002 Mutations of the BRAF gene in human cancer. Nature 417:949-954
24. Pollock PM, Harper UL, Hansen KS, Yudt LM, Stark M, Robbins CM, Moses TY, Hostetter G, Wagner U, Kakareka J, Salem G, Pohida T, Heenan P, Duray P, Kallioniemi O, Hayward NK, Trent JM, Meltzer PS 2003 High frequency of BRAF mutations in nevi. Nat Genet 33:19-20
25. Xing M, Usadel H, Cohen Y, Tokumaru Y, Guo Z, Westra WB, Tong BC, Tallini G, Udelsman R, Califano JA, Ladenson PW, Sidransky D 2003 Methylation of the thyroid-stimulating hormone receptor gene in epithelial thyroid tumors: a marker of malignancy and a cause of gene silencing. Cancer Res 63:2316-2321
26. Santoro M, Thomas GA, Vecchio G, Williams GH, Fusco A, Chiappetta G, Pozcharskaya V, Bogdanova TI, Demidchik EP, Cherstvoy ED, Voscoboinik L, Tronko ND, Carss A, Bunnell H, Tonnachera M, Parma J, Dumont JE, Keller G, Hofler H, Williams ED 2000 Gene rearrangement and Chernobyl related thyroid cancers. Br J Cancer 82:315-322
27. Meier CA 2000 Thyroid nodules: pathogenesis, diagnosis and treatment. Bail-Meres Best Pract Res Clin Endocrinol Metab 14:559-575
28. van Weering DH, Medema JP, van Puijenbroek A, Burgering BM, Baas PD, Bos JL 1995 Ret receptor ryrosine kinase activates extracellular signal-regulated kinase 2 in SK-N-MC cells. Oncogene 11:2207-2214
29. van Puijenbroek AA, van Weering DH, van den Brink CE, Bos JL, van der Saag PT, de Laat SW, den Hertog J 1997 Cell scattering of SK-N-MC neuroepithelioma cells in response to Ret and FGF receptor tyrosine kinase activation is correlated with sustained ERK2 activation. Oncogene 14:1147-1157